SMAD7 polymorphisms and colorectal cancer risk: a meta-analysis of case-control studies
Open Access
- 27 September 2016
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (46) , 75561-75570
Abstract
SMAD7 polymorphisms and colorectal cancer risk: a meta-analysis of case-control studiesKeywords
This publication has 55 references indexed in Scilit:
- Are SMAD7 rs4939827 and CHI3L1 rs4950928 polymorphisms associated with colorectal cancer in Egyptian patients?Tumor Biology, 2016
- Cumulative Small Effect Genetic Markers and the Risk of Colorectal Cancer in Poland, Estonia, Lithuania, and LatviaGastroenterology Research and Practice, 2015
- Single nucleotide polymorphisms in colorectal cancer: associations with tumor site and TNM stage.2012
- Replication study of SNP associations for colorectal cancer in Hong Kong ChineseBritish Journal of Cancer, 2010
- Enrichment of Low Penetrance Susceptibility Loci in a Dutch Familial Colorectal Cancer CohortCancer Epidemiology, Biomarkers & Prevention, 2009
- TGFβ in CancerCell, 2008
- TGFβ–SMAD signal transduction: molecular specificity and functional flexibilityNature Reviews Molecular Cell Biology, 2007
- Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cellsPlatelets, 2007
- Activated hepatic stellate cells induce tumor progression of neoplastic hepatocytes in a TGF‐β dependent fashionJournal of Cellular Physiology, 2006
- Systematic Reviews on Rehabilitation InterventionsArchives of Physical Medicine and Rehabilitation, 2006